Paper16907
Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase.
Abuchowski A and 4 others. J Biol Chem, 1977. Cited by 772 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. Papers, record 16907. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16907
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Catalase | Major topic |
| Polyethylene Glycols | Major topic |
| Acatalasia | |
| Animals | |
| Antibody Formation | |
| Cattle | |
| Complement Fixation Tests | |
| Hot Temperature | |
| Hydrogen-Ion Concentration | |
| Immunodiffusion | |
| Liver | |
| Mice | |
| Molecular Weight | |
| Peptide Hydrolases | |
| Rabbits |
Source PubMed
Cited by249
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 772 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42877048 | Chemically modified gelatin derivatives: synthetic strategies, physicochemical properties, biodegradation, drug delivery and biomedical applications. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42877048 | PubMed |
| 42797535 | Ritonavir-Loaded PEG-b-PCL Polymeric Micelles: Reduced Excipient Requirements and Comparable Oral Pharmacokinetics in Rats. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42797535 | PubMed |
| 42734265 | Effective Reduction of Anti-PEG Antibody Recognition via PEG Copolymers with Ethyl Glycidyl Ether and Isopropyl Glycidyl Ether. | Biomacromolecules | 2026 | https://conductscience.org/library/papers/42734265 | PubMed |
| 42534707 | Nanoscopic Characterization of the Thermal Phase Behavior of Random Poly(ethylene glycol-glycidyl methyl ether) Copolymers (rPEGs). | Macromolecules | 2026 | https://conductscience.org/library/papers/42534707 | PubMed |
| 42513180 | Hybrid Mucointeractive Delivery Systems-Alternative Approaches to Mucosal Delivery. | Molecules | 2026 | https://conductscience.org/library/papers/42513180 | PubMed |
| 42510422 | Nanoparticle-Enabled Modulation of the Bone Immune Microenvironment for Enhanced Regeneration. | Bioengineering (Basel) | 2026 | https://conductscience.org/library/papers/42510422 | PubMed |
| 42438481 | Monodisperse PEG engineering for quantifiable surface conjugation on PLGA nanoparticles. | Nanoscale Adv | 2026 | https://conductscience.org/library/papers/42438481 | PubMed |
| 42253771 | Design Principles, Synthetic Strategies, and Biomedical Applications of Peptide-Polymer Conjugates. | Polym Sci Technol | 2026 | https://conductscience.org/library/papers/42253771 | PubMed |
| 41445782 | Functionalized albumin nanoparticles: A multifunctional platform for enhanced brain drug delivery. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/41445782 | PubMed |
| 41442576 | A Non-Antigenic Randomized Polyethylene Glycol/Poly(2-Phenyl-2-Oxazine)-Based Drug Delivery Platform. | Macromol Rapid Commun | 2026 | https://conductscience.org/library/papers/41442576 | PubMed |
| 41255259 | Overcoming PEG Antigenicity: Statistical PEG Isomers Reduce Antibody Binding. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41255259 | PubMed |
| 41048377 | Optimising Monoclonal Antibody Drug Development for Inflammatory Bowel Disease. | Clin Exp Gastroenterol | 2025 | https://conductscience.org/library/papers/41048377 | PubMed |
| 40715149 | Secondary ions mass spectrometric method for assessing surface density of pegylated liposomal nanomedicines. | Sci Rep | 2025 | https://conductscience.org/library/papers/40715149 | PubMed |
| 40476701 | pH Controlled Activation and Stabilization of Enzymes Using Responsive Polymer-Bioconjugates. | Biomacromolecules | 2025 | https://conductscience.org/library/papers/40476701 | PubMed |
| 40264371 | PEGylation technology: addressing concerns, moving forward. | Drug Deliv | 2025 | https://conductscience.org/library/papers/40264371 | PubMed |
| 39996639 | Hydrogels from Protein-Polymer Conjugates: A Pathway to Next-Generation Biomaterials. | Gels | 2025 | https://conductscience.org/library/papers/39996639 | PubMed |
| 39856033 | Chemical catalyst manipulating cancer epigenome and transcription. | Nat Commun | 2025 | https://conductscience.org/library/papers/39856033 | PubMed |
| 39802382 | Advancing Therapeutic Strategies with Polymeric Drug Conjugates for Nucleic Acid Delivery and Treatment. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/39802382 | PubMed |
| 39697984 | Bioprinting extracellular vesicles as a "cell-free" regenerative medicine approach. | Extracell Vesicles Circ Nucl Acids | 2023 | https://conductscience.org/library/papers/39697984 | PubMed |
| 39534681 | Sericin coats of silk fibres, a degumming waste or future material? | Mater Today Bio | 2024 | https://conductscience.org/library/papers/39534681 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16907
GET https://conductscience.org/api/papers/v1/16907/cited_by?page=2